Omni Bio Pharmaceutical Inc (OMBP) financial statements (2021 and earlier)

Company profile

Business Address 181 W BOARDWALK DRIVE
FORT COLLINS, CO 80525
State of Incorp. CO
Fiscal Year End March 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2014
Q3
9/30/2014
Q2
6/30/2014
Q1
3/31/2014
Q4
12/31/2013
Q3
9/30/2013
Q2
6/30/2013
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8527106522714857801,262
Cash and cash equivalents8527106522714857801,262
Other current assets701111423269106128
Total current assets:9228217943045548871,390
Noncurrent Assets
Intangible assets, net (including goodwill)60616263656667
Intangible assets, net (excluding goodwill)60616263656667
Regulated entity, other noncurrent assets  104130156192219
Deferred costs5177     
Total noncurrent assets:111138166193221258286
TOTAL ASSETS:1,0339599594977751,1441,676
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4693486596695993
Accounts payable  1913511
Accrued liabilities151815388565482
Interest and dividends payable31926711    
Debt206345     
Other undisclosed current liabilities9271,525409    
Total current liabilities:1,6032,21847396695993
Noncurrent Liabilities
Long-term debt and lease obligation  254282255277251
Long-term debt, excluding current maturities  254282255277251
Other undisclosed noncurrent liabilities2,2536011,2141,0039131,0011,053
Total noncurrent liabilities:2,2536011,4681,2851,1671,2791,304
Total liabilities:3,8552,8191,9411,3811,2361,3371,397
Stockholders' equity
Stockholders' equity attributable to parent, including:(2,823)(1,859)(982)(884)(461)(193)279
Common stock40393939393838
Additional paid in capital46,89146,45746,34545,60945,59245,10544,937
Other undisclosed stockholders' equity attributable to parent(49,754)(48,355)(47,365)(46,532)(46,091)(45,336)(44,696)
Other undisclosed stockholders' equity0      
Total stockholders' equity:(2,823)(1,859)(982)(884)(461)(193)279
TOTAL LIABILITIES AND EQUITY:1,0339599594977751,1441,676

Income statement (P&L) ($ in thousands)

12/31/2014
Q3
9/30/2014
Q2
6/30/2014
Q1
3/31/2014
Q4
12/31/2013
Q3
9/30/2013
Q2
6/30/2013
Q1
Operating expenses(522)(614)(533)(297)(446)(638)(531)
Operating loss:(522)(614)(533)(297)(446)(638)(531)
Nonoperating expense(877)(376)(300)(144)(309)(2)(150)
Investment income, nonoperating    (44)39(5)
Interest and debt expense(134)   (28)(28) 
Net loss:(1,533)(990)(834)(440)(783)(668)(681)
Other undisclosed net income attributable to parent134   2828 
Net loss available to common stockholders, diluted:(1,399)(990)(834)(440)(755)(640)(681)

Comprehensive Income ($ in thousands)

12/31/2014
Q3
9/30/2014
Q2
6/30/2014
Q1
3/31/2014
Q4
12/31/2013
Q3
9/30/2013
Q2
6/30/2013
Q1
Net loss:(1,533)(990)(834)(440)(783)(668)(681)
Comprehensive loss, net of tax, attributable to parent:(1,533)(990)(834)(440)(783)(668)(681)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: